Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT03033758
Eligibility Criteria:
Inclusion Criteria:
* Male and Female
* Patients about to start treatment with the inhaled combination of budesonide and formoterol fumarate dihydrate at doses 100 / 6mcg, 200 / 6mcg, 400/12 mcg, through Elpenhlaler device
* Regular treatment of asthma, wherein the administration of the combination (inhaled corticosteroid and long-action beta2-agonist) is appropriate
* Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled beta2-agonists short-acting
* Patients who signed Informed Consent Patients eligible to follow the study procedures
Exclusion Criteria:
* Patients who will be treated out of SpC
* Patients without Informed Consent
* Patients not eligible to follow the study procedures
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03033758
Study Brief:
Protocol Section:
NCT03033758